Low-Dose Subtle Effects
Small placeholder note on subtle low-dose effects.
- 1–5 mg: Typical dose (placeholder range)
- Low: Subjective intensity (placeholder)
- Rare: Mystical content (placeholder)
- ~3–4 hr: Duration (placeholder)
Subtle mood and sensory shifts
Placeholder: mild mood lift and light sensory change at low dose.
Moderate-Dose Perceptual Changes
Short placeholder on rising perceptual change with dose.
- 10–15 mg: Typical dose (placeholder range)
- Moderate: Visual change (placeholder)
- Partial: Ego dissolution (placeholder)
- ~30 min: Onset (placeholder)
Perceptual and cognitive shifts scale with dose
Placeholder: visuals and thought patterns shift more as dose increases.
High-Dose Mystical Experience Threshold
Short placeholder describing the mystical-experience dose threshold.
- ~18–20 mg: Threshold dose (placeholder, sensitivity-adjusted)
- High: Mystical rate (placeholder)
- Common: Unity experience (placeholder)
- Strong: Ego dissolution (placeholder)
A dose threshold triggers full mystical-type states
Placeholder: crossing effective dose threshold reliably yields mystical content.
Mystical Experience Questionnaire Scoring
Short placeholder on MEQ30 scoring of the session.
- 0–100: MEQ scale (placeholder, composite score)
- ≥60: Complete experience (placeholder cutoff)
- 4: Domains (placeholder: unity, noetic, transcendence, ineffability)
- 30: Items (placeholder questionnaire length)
Four domains combine into one MEQ score
Placeholder: unity, sacredness, noetic quality, and ineffability sum to MEQ.
Correlation With Therapeutic Outcome
Short placeholder on MEQ predicting therapeutic outcome.
- Strong: Correlation (placeholder, MEQ vs outcome)
- +: Complete-experience bonus (placeholder threshold effect)
- Symptom change: Outcome measure (placeholder)
- Weeks–months: Follow-up (placeholder)
Higher MEQ predicts better clinical response
Placeholder: sessions crossing the complete-experience cutoff show larger gains.
Placeholder key insight: mystical intensity, not dose alone, best predicts benefit.